Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia : A Prospective Study for a Blood Diagnostic Test in Alzheimer's Disease - (Protocol n° EHTAD/002).

NCT00880347 is registered in ClinicalTrials.gov with Exonhit as lead sponsor.

NCT NCT00880347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00880347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia : A Prospective Study for a Blood Diagnostic Test in Alzheimer's Disease - (Protocol n° EHTAD/002).
Lead sponsor
Exonhit
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2008
Completion date
February 28, 2011
Enrollment
550 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, dementia